Our lab creates in vitro models of human neurodegenerative diseases by converting patients’ skin fibroblasts into disease-affected neural cells. This enables us to screen thousands of drug-like compounds in search of potential therapeutics that slow or stop the degeneration of these cells in petri dishes — and eventually in patients.
- The Broad Foundation awards $1 million to early-stage stem cell research projects September 29, 2017
- USC Stem Cell researcher Justin Ichida honored as a champion in the fight against ALS September 25, 2017
- Verge Genomics announces a multi-institution collaboration with Columbia University, MGH, USC and the University of Michigan to advance ALS research September 22, 2017